C-X-C chemokine receptor 7: A functionally associated molecular marker for bladder cancer

Cancer

Volumn 119, Issue 1, 2013, Pages 61-71

  Yates, Travis J ^a   Knapp, Judith ^b   Gosalbez, Miguel ^b   Lokeshwar, Soum D ^a   Gomez, Christopher S ^b   Benitez, Anaid ^b   Ekwenna, Obi O ^b   Young, Ezekiel E ^b   Manoharan, Murugesan ^b   Lokeshwar, Vinata B ^b  

^a UNIVERSITY OF MIAMI   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

bladder cancer; CXCR4; CXCR7; metastasis; molecular marker

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR7; CYCLIN D1; EPIDERMAL GROWTH FACTOR RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLADDER CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER GRADING; CANCER TISSUE; CELL GROWTH; CELL MOTILITY; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SPECIFIC MORTALITY; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; FEMALE; GENE REPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; MORTALITY; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; TRANSIENT EXPRESSION; TRANSIENT OVEREXPRESSION; UPREGULATION; URINALYSIS;

AGED; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; RECEPTORS, CXCR; RECEPTORS, CXCR4; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION; URINARY BLADDER NEOPLASMS;

EID: 84872774600     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.27661     Document Type: Article

References (31)

1. Kaufman DS, Shipley WU, Feldman AS,. Bladder cancer. Lancet. 2009; 374: 239-249.
2. Vandercappellen J, Van Damme J, Struyf S,. The role of CXC chemokines and their receptors in cancer. Cancer Lett. 2008; 267: 226-244.
3. Maksym RB, Tarnowski M, Grymula K, et al. The role of stromal-derived factor-1-CXCR7 axis in development and cancer. Eur J Pharmacol. 2009; 625: 31-40.
4. Sun X, Cheng G, Hao M, et al. CXCL12/CXCR4/CXCR7 chemokine axis and cancer progression. Cancer Metastasis Rev. 2010; 29: 709-722.
5. Teicher BA, Fricker SP,. CXCL12 (SDF-1)/CXCR4 pathway in cancer. Clin Cancer Res. 2010; 16: 2927-2931.
6. Altenburg JD, Broxmeyer HE, Jin Q, Cooper S, Basu S, Alkhatib G,. A naturally occurring splice variant of CXCL12/stromal cell-derived factor 1 is a potent human immunodeficiency virus type 1 inhibitor with weak chemotaxis and cell survival activities. J Virol. 2007; 81: 8140-8148.
7. Liu Y, Ji R, Li J, et al. Correlation effect of EGFR and CXCR4 and CCR7 chemokine receptors in predicting breast cancer metastasis and prognosis. J Exp Clin Cancer Res. 2010; 29: 16-25.
8. Andre F, Xia W, Conforti R, et al. CXCR4 expression in early breast cancer and risk of distant recurrence. Oncologist. 2009; 14: 1182-1188.
9. Saigusa S, Toiyama Y, Tanaka K, et al. Stromal CXCR4 and CXCL12 expression is associated with distant recurrence and poor prognosis in rectal cancer after chemoradiotherapy. Ann Surg Oncol. 2010; 17: 2051-2058.
10. Retz MM, Sidhu SS, Blaveri E, et al. CXCR4 expression reflects tumor progression and regulates motility of bladder cancer cells. Int J Cancer. 2005; 114: 182-189.
11. Eisenhardt A, Frey U, Tack M, et al. Expression analysis and potential functional role of the CXCR4 chemokine receptor in bladder cancer. Eur Urol. 2005; 47: 111-117.
12. Pignot G, Bieche I, Vacher S, et al. Large-scale real-time reverse transcription-PCR approach of angiogenic pathways in human transitional cell carcinoma of the bladder: identification of VEGFA as a major independent prognostic marker. Eur Urol. 2009; 56: 678-688.
13. Nishizawa K, Nishiyama H, Oishi S, et al. Fluorescent imaging of high-grade bladder cancer using a specific antagonist for chemokine receptor CXCR4. Int J Cancer. 2010; 127: 1180-1187.
14. D'Alterio C, Consales C, Polimeno M, et al. Concomitant CXCR4 and CXCR7 expression predicts poor prognosis in renal cancer. Curr Cancer Drug Targets. 2010; 10: 772-781.
15. Iwakiri S, Mino N, Takahashi T, et al. Higher expression of chemokine receptor CXCR7 is linked to early and metastatic recurrence in pathological stage I nonsmall cell lung cancer. Cancer. 2009; 115: 2580-2593.
16. Wang J, Shiozawa Y, Wang J, et al. The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer. J Biol Chem. 2008; 283: 4283-4294.
17. Burns JM, Summers BC, Wang Y, et al. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med. 2006; 203: 2201-2213.
18. Miao Z, Luker KE, Summers BC, et al. CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature. Proc Natl Acad Sci U S A. 2007; 104: 15735-15740.
19. Singh RK, Lokeshwar BL,. The IL-8-regulated chemokine receptor CXCR7 stimulates EGFR signaling to promote prostate cancer growth. Cancer Res. 2011; 71: 3268-3277.
20. Masters JR, Hepburn PJ, Walker L, et al. Tissue culture model of transitional cell carcinoma: characterization of twenty-two human urothelial cell lines. Cancer Res. 1986; 46: 3630-3636.
21. Lokeshwar VB, Lopez LE, Munoz D, et al. Antitumor activity of hyaluronic acid synthesis inhibitor 4-methylumbelliferone in prostate cancer cells. Cancer Res. 2010; 70: 2613-2623.
22. Kramer MW, Escudero DO, Lokeshwar SD, et al. Association of hyaluronic acid family members (HAS1, HAS2, and HYAL-1) with bladder cancer diagnosis and prognosis. Cancer. 2010; 117: 1197-1209.
23. Kollmar O, Rupertus K, Scheuer C, Nickels RM, Haberl GC, Tilton B, et al. CXCR4 and CXCR7 regulate angiogenesis and CT26.WT tumor growth independent from SDF-1. Int J Cancer. 2010; 126: 1302-1315.
24. Hattermann K, Held-Feindt J, Lucius R, et al. The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates antiapoptotic effects. Cancer Res. 2010; 70: 3299-3308.
25. Odemis V, Boosmann K, Heinen A, Küry P, Engele J,. CXCR7 is an active component of SDF-1 signalling in astrocytes and Schwann cells. J Cell Sci. 2010; 123: 1081-1088.
26. Schulze WX, Deng L, Mann M,. Phosphotyrosine interactome of the ErbB-receptor kinase family. Mol Syst Biol. 2005; 1: 1-13.
27. Sato K, Nagao T, Iwasaki T, Nishihira Y, Fukami Y,. Src-dependent phosphorylation of the EGF receptor Tyr-845 mediates Stat-p21waf1 pathway in A431 cells. Genes Cells. 2003; 8: 995-1003.
28. Zheng K, Li HY, Su XL, et al. Chemokine receptor CXCR7 regulates the invasion, angiogenesis and tumor growth of human hepatocellular carcinoma cells. J Exp Clin Cancer Res. 2010; 29: 31-45.
29. Monnier J, Boissan M, L'Helgoualc'h A, et al. CXCR7 is up-regulated in human and murine hepatocellular carcinoma and is specifically expressed by endothelial cells. Eur J Cancer. 2012; 48: 138-148.
30. Würth R, Barbieri F, Bajetto A, et al. Expression of CXCR7 chemokine receptor in human meningioma cells and in intratumoral microvasculature. J Neuroimmunol. 2011; 234: 115-123.
31. Xu H, Wu Q, Dang S, et al. Alteration of CXCR7 expression mediated by TLR4 promotes tumor cell proliferation and migration in human colorectal carcinoma. PLoS One. 2011; 6 (12): e27399.